Stericycle (NASDAQ:SRCL) Research Coverage Started at StockNews.com

Posted by Defense World Staff on Jul 15th, 2024

Equities research analysts at StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the business services provider’s stock.

Other analysts have also issued research reports about the stock. Truist Financial lifted their price objective on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods increased their price target on shares of Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, Robert W. Baird decreased their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, April 26th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Stericycle currently has an average rating of “Hold” and an average target price of $74.00.

Check Out Our Latest Stock Analysis on SRCL

Stericycle Price Performance

SRCL stock opened at $58.27 on Monday. The company has a market cap of $5.41 billion, a PE ratio of -264.86, a price-to-earnings-growth ratio of 3.14 and a beta of 1.11. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The stock has a 50-day moving average price of $54.05 and a two-hundred day moving average price of $51.39. Stericycle has a 12-month low of $37.78 and a 12-month high of $59.45.

Stericycle (NASDAQ:SRCL – Get Free Report) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter in the previous year, the business earned $0.49 EPS. The company’s revenue for the quarter was down 2.8% on a year-over-year basis. As a group, research analysts predict that Stericycle will post 2.32 EPS for the current year.

Hedge Funds Weigh In On Stericycle

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Clearstead Trust LLC acquired a new stake in Stericycle during the 1st quarter worth about $25,000. Principal Securities Inc. purchased a new stake in shares of Stericycle during the fourth quarter worth $41,000. GAMMA Investing LLC boosted its position in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 516 shares during the last quarter. TFO Wealth Partners LLC increased its position in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after purchasing an additional 893 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new stake in shares of Stericycle during the 1st quarter valued at about $44,000. Institutional investors and hedge funds own 98.82% of the company’s stock.

Stericycle Company Profile

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.